Zhang et al. observed that baicalin reduces serum TNF-α, IL-1β levels, monocyte chemoattractant protein-1 (MCP-1) production, macrophage influx, and nuclear factor-κB (NF-κB) activation, thus inhibiting dietary NASH symptoms induced by MCD [25]. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatohepatitis.